A Texas judge ruled that Keurig Dr. Pepper Inc. can end its partnership with the distribution and bottling operations in ...

Keurig Dr Pepper’s first quarter results were marked by solid top and bottom-line performance, surpassing Wall Street’s expectations. Despite this, the market responded negatively, with management ...

Barclays lifted their price objective on shares of Keurig Dr Pepper from $37.00 to $38.00 and gave the stock an “overweight” rating in a research report on Monday, April 28th.

In a report released today, Lauren Lieberman from Barclays maintained a Buy rating on Keurig Dr Pepper (KDP – Research Report), with a price target of $38.00.

Barclays analyst Lauren Lieberman maintained a Buy rating on Keurig Dr Pepper (KDP – Research Report) today and set a price target of $37.00. The company’s shares closed yesterday at $35.19.

Keurig Dr Pepper has a 12 month low of $30.12 and a 12 month high of $38.28. The stock has a market capitalization of $47.45 billion, a P/E ratio of 21.19, a price-to-earnings-growth ratio of 2.42 ...

Keurig Dr Pepper has booked fourth-quarter results that beat analyst estimates despite the US group recording a $718m impairment for the period. The Canada Dry owner exceeded market expectations in ...

We recently published a list of 12 Best FMCG Stocks To Buy According to Hedge Funds. In this article, we are going to take a ...